Today, the country's first Specialized Center for the Treatment of inflammatory bowel Diseases (IBD), short bowel syndrome (CCM) and nutritional Correction has opened on the basis of the Research Institute of Cardiology and Internal Diseases.
Inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, are becoming more common worldwide. About 6 million people suffer from IBD, with the highest prevalence in high-income countries such as the United States and European countries. The number of cases is also increasing in developing regions, including Asia, where the incidence was previously relatively low.
It is estimated that there are about 5-10 cases of IBD for every 100,000 people in Kazakhstan, and this figure may continue to grow, especially given improved diagnosis and increased awareness of the diseases.
Short bowel syndrome is a rare but serious condition that usually occurs after surgical removal of significant areas of the small intestine due to injuries, diseases or complications of IBD, such as Crohn's disease.
Inflammatory bowel diseases and short bowel syndrome are a major challenge for national health, requiring a comprehensive solution and the coordinated work of a well-trained multidisciplinary team. The center will provide specialized care to this category of patients, including high-quality diagnostics, modern treatment programs and psychosocial support. One of the key areas will be nutritional correction, including advice on clinical nutrition (including enteral and parenteral nutrition).
"The main objectives of the center are to improve the quality of life of patients with IBD and CCM, as well as to improve the prognosis and prevent possible complications. The uniqueness of our center lies not only in the availability of modern technologies for diagnosis and a large arsenal of therapy, but also in the presence of a multidisciplinary team, which allows patients to receive a full range of services for rehabilitation and treatment. We strive to ensure that every patient receives high-quality care, as well as the support necessary to return to a full life," says Jamila Kaibullayeva, Deputy Chairman of the Board of the Research Institute of Cardiology and Internal Diseases for Scientific, Clinical and innovative activities.

Source : https://www.gov.kz/memleket/entities/dsm/press/news/details/879207